Cohen Yuval (CIK 1626003) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-10). Recent activity: Sell CRBP (17,000 shares), Sell CRBP (13,871 shares), Buy CRBP (50,000 shares), Buy CRBP (18,660 shares), Sell CRBP (18,660 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | Sell | 17,000 | $171,396 |
| 2026-02-18 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | Sell | 13,871 | $107,916 |
| 2026-01-16 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | Buy | 50,000 | $0 |
| 2025-10-27 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | Buy | 18,660 | $79,492 |
| 2025-10-27 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | Sell | 18,660 | $317,407 |
| 2025-10-27 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | Buy | 8,973 | $38,225 |
| 2025-10-27 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | Sell | 8,973 | $153,797 |
Source: SEC Form 4 filings · as of 2026-08-10